Open Nav

Fry Laboratories, LLC

  • Jeremy Ellis, Fry Laboratories, LLC

Seeking funding to support manufacturing and distribution of kits.

  • Date:Thursday, October 18
  • Time:10:15 AM - 10:30 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Fry Laboratories, LLC is a clinical stage company with a long track record in the development and translation of novel diagnostics technologies into routine clinical use. We are committed to understanding chronic diseases and contributing to their cure through advancements in diagnostics and basic science research. Our signature technology RIDI(TM), Rapid Infectious Disease Identification system, allows for rapid hypothesis free detection of bacteria in clinical samples. We propose to manufacture and distribute kits that will enable clinical labs to perform this advanced diagnostic assay by simplifying the chemistry and bioinformatics hurdles. The kits and systems are sustainable in a clinical laboratory space and are clinically compatible in both reporting and analysis. By democratizing our existing clinical assay we aim to improve patient care globally using the unmatched capability of Next Generation DNA Sequencing. All development at Fry Laboratories, LLC are self funded.
  • Company
  • Company HQ City:Scottsdale
  • Company HQ Country:United States
  • Company HQ State:Arizona                        
  • CEO/Top Company Official:Judith Joseph
  • Year Founded:2009
  • Main Therapeutic Focus:Diagnostics
  • Lead Product in Development :Rapid Infectious Disease Identification Kits using Next Generation DNA Sequencing
  • Development Phase of Primary Product:Other/Not Applicable
  • Previous and Current Investors:0
  • Size of Last Investment Round:0
  • Total Amount Raised to Date, In All Rounds:0
Jeremy Ellis
Fry Laboratories, LLC